Ontario’s Progressive Conservative government appears to be backing away from planned budget cuts to the province’s MedsCheck program on the heels of the final report of the Wettlaufer inquiry.
The wild ride for CannTrust Holdings Inc. shareholders continued Monday morning after the company's stock plunged on news that its manufacturing facility in Vaughan, Ont., has been rated non-compliant by Health Canada.
The federal government is overhauling the way it regulates the cost of patented medicines, including ending comparisons to the United States — changes that Canada's health minister is billing as the biggest step towards lower drug prices in a generation.
